ATE277617T1 - Neue behandlungen für nervenkrankheiten - Google Patents
Neue behandlungen für nervenkrankheitenInfo
- Publication number
- ATE277617T1 ATE277617T1 AT99918423T AT99918423T ATE277617T1 AT E277617 T1 ATE277617 T1 AT E277617T1 AT 99918423 T AT99918423 T AT 99918423T AT 99918423 T AT99918423 T AT 99918423T AT E277617 T1 ATE277617 T1 AT E277617T1
- Authority
- AT
- Austria
- Prior art keywords
- new treatments
- nervous diseases
- reboxetine
- noradrenaline reuptake
- new
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 2
- CBQGYUDMJHNJBX-RTBURBONSA-N reboxetine Chemical compound CCOC1=CC=CC=C1O[C@H](C=1C=CC=CC=1)[C@@H]1OCCNC1 CBQGYUDMJHNJBX-RTBURBONSA-N 0.000 abstract 2
- 229960003770 reboxetine Drugs 0.000 abstract 2
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000002858 neurotransmitter agent Substances 0.000 abstract 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 abstract 1
- 229940126569 noradrenaline reuptake inhibitor Drugs 0.000 abstract 1
- 230000000966 norepinephrine reuptake Effects 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Mobile Radio Communication Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8163298P | 1998-04-13 | 1998-04-13 | |
| IT98MI000870 IT1305322B1 (it) | 1998-04-23 | 1998-04-23 | Uso di reboxetina per il trattamento di disturbi nervosi |
| US8503398P | 1998-05-11 | 1998-05-11 | |
| PCT/US1999/004288 WO1999052518A2 (en) | 1998-04-13 | 1999-04-02 | New treatments for nervous disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE277617T1 true ATE277617T1 (de) | 2004-10-15 |
Family
ID=11379879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99918423T ATE277617T1 (de) | 1998-04-13 | 1999-04-02 | Neue behandlungen für nervenkrankheiten |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6391876B1 (de) |
| EP (1) | EP1071418B1 (de) |
| JP (1) | JP2002511408A (de) |
| KR (1) | KR100555279B1 (de) |
| CN (1) | CN1197569C (de) |
| AT (1) | ATE277617T1 (de) |
| AU (1) | AU755612B2 (de) |
| BR (1) | BR9909476A (de) |
| CA (1) | CA2320722A1 (de) |
| DE (1) | DE69920679T2 (de) |
| DK (1) | DK1071418T3 (de) |
| EA (1) | EA003546B1 (de) |
| ES (1) | ES2228035T3 (de) |
| HU (1) | HUP0101748A3 (de) |
| IL (1) | IL138887A0 (de) |
| IT (1) | IT1305322B1 (de) |
| NO (1) | NO20005131L (de) |
| NZ (1) | NZ507693A (de) |
| PL (1) | PL194039B1 (de) |
| PT (1) | PT1071418E (de) |
| SI (1) | SI1071418T1 (de) |
| SK (1) | SK14482000A3 (de) |
| TR (1) | TR200002970T2 (de) |
| WO (1) | WO1999052518A2 (de) |
| ZA (1) | ZA200004480B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6500827B2 (en) * | 1998-05-08 | 2002-12-31 | Pharmacia & Upjohn Company | Drug combinations |
| EP1459750B1 (de) * | 1999-07-01 | 2005-06-01 | Pharmacia & Upjohn Company LLC | (S,S)-Reboxetin zur Behandlung von Fibromyalgie und anderen somatoformen Störungen |
| DE60035232T2 (de) | 1999-07-01 | 2008-02-14 | Pharmacia & Upjohn Co. Llc, Kalamazoo | (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom |
| PL366119A1 (en) * | 2000-11-15 | 2005-01-24 | Eli Lilly And Company | Treatment of anxiety disorders |
| DE60328787D1 (de) * | 2002-06-17 | 2009-09-24 | Pfizer Italia Srl | Pharmazeutische salze von reboxetin |
| US20100069389A1 (en) * | 2008-09-06 | 2010-03-18 | Bionevia Pharmaceuticals, Inc. | Novel forms of reboxetine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL56369A (en) * | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
| GB8419683D0 (en) | 1984-08-02 | 1984-09-05 | Erba Farmitalia | 3-substituted derivatives of 1-amino-2-hydroxy-propane |
| GB2167407B (en) * | 1984-11-22 | 1988-05-11 | Erba Farmitalia | Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof |
| WO1999020279A1 (en) * | 1997-10-17 | 1999-04-29 | Eli Lilly And Company | Potentiation of pharmaceuticals |
-
1998
- 1998-04-23 IT IT98MI000870 patent/IT1305322B1/it active
-
1999
- 1999-04-02 NZ NZ507693A patent/NZ507693A/en unknown
- 1999-04-02 BR BR9909476-2A patent/BR9909476A/pt not_active Application Discontinuation
- 1999-04-02 ES ES99918423T patent/ES2228035T3/es not_active Expired - Lifetime
- 1999-04-02 DK DK99918423T patent/DK1071418T3/da active
- 1999-04-02 WO PCT/US1999/004288 patent/WO1999052518A2/en not_active Ceased
- 1999-04-02 IL IL13888799A patent/IL138887A0/xx not_active IP Right Cessation
- 1999-04-02 EP EP99918423A patent/EP1071418B1/de not_active Expired - Lifetime
- 1999-04-02 PT PT99918423T patent/PT1071418E/pt unknown
- 1999-04-02 EA EA200001058A patent/EA003546B1/ru not_active IP Right Cessation
- 1999-04-02 SI SI9930684T patent/SI1071418T1/xx unknown
- 1999-04-02 CA CA002320722A patent/CA2320722A1/en not_active Abandoned
- 1999-04-02 JP JP2000543128A patent/JP2002511408A/ja active Pending
- 1999-04-02 KR KR1020007011336A patent/KR100555279B1/ko not_active Expired - Fee Related
- 1999-04-02 PL PL99346294A patent/PL194039B1/pl unknown
- 1999-04-02 TR TR2000/02970T patent/TR200002970T2/xx unknown
- 1999-04-02 AT AT99918423T patent/ATE277617T1/de not_active IP Right Cessation
- 1999-04-02 DE DE69920679T patent/DE69920679T2/de not_active Expired - Fee Related
- 1999-04-02 AU AU36351/99A patent/AU755612B2/en not_active Ceased
- 1999-04-02 SK SK1448-2000A patent/SK14482000A3/sk unknown
- 1999-04-02 HU HU0101748A patent/HUP0101748A3/hu active IP Right Revival
- 1999-04-02 US US09/673,768 patent/US6391876B1/en not_active Expired - Fee Related
- 1999-04-02 CN CNB99804010XA patent/CN1197569C/zh not_active Expired - Fee Related
-
2000
- 2000-08-29 ZA ZA200004480A patent/ZA200004480B/en unknown
- 2000-10-12 NO NO20005131A patent/NO20005131L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA43385C2 (uk) | Спосіб лікування синдрому дефіциту уваги/гіперактивності | |
| DE69920679D1 (de) | Neue behandlungen für nervenkrankheiten | |
| MY134110A (en) | Combinations of reboxetine and neuroleptic agents | |
| TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
| ATE329588T1 (de) | Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns- erkrankungen | |
| NO2012015I2 (no) | Dapoxetine | |
| WO2002077198A3 (en) | Methods of modulating angiogenesis | |
| AR021155A1 (es) | Tratamiento de desordenes neuroticos | |
| ES2118569T3 (es) | Procedimiento para la regeneracion de un catalizador. | |
| MY136367A (en) | Treatment of cognitive failure | |
| PT1075264E (pt) | Novas combinacoes farmacologicas de reboxetina e pindolol | |
| WO2002040006A3 (en) | Treatment of anxiety disorders | |
| CO4950552A1 (es) | Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador b | |
| PT1054671E (pt) | Nova utilizacao da ropivacaina para o controlo da dor | |
| BR0115880A (pt) | Emprego de compostos ciclohexanona de 6-dimetilaminometila-1-fenil para o tratamento da incontinência urinária | |
| DK1455770T3 (da) | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser | |
| ECSP034647A (es) | Uso de factor vii actividad de coagulacion para tratar sangrados graves inducidos por terapia | |
| ATE406880T1 (de) | Behandlung von motorischen veränderungen mit 5- hydrxoytryptamin 1a rezeptor aktivität verstärkenden wirkstoffen | |
| ES2122953T1 (es) | Utilizacion de inhibidores pkc para la fabricacion de un medicamento para el tratamiento de las disfunciones sexuales. | |
| CY1110278T1 (el) | Μεθοδος διαλογης παραγοντων ικανων να θεραπευουν την παχυσαρκια | |
| DK1558610T3 (da) | Substituerede aminoquinuclidinforbindelser og deres anvendelse som delta-opioidreceptorligander | |
| FI972378A0 (fi) | Menetelmä orgaanisia ja epäorgaanisia yhdisteitä sisältävien jätevesien katalyyttiseksi käsittelemiseksi | |
| DE50115630D1 (de) | Katalysator für die hydrierung von ungesättigten kohlenwasserstoffen | |
| ECSP992873A (es) | Metodo para tratar desordenes compulsivos, obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso, y autismo (caso cn0823) | |
| ES1040148U (es) | Criba de levas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1071418 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |